Sacubitril/Valsartan (LCZ696) is an Dual NEP/RAAS Inhibitor for Heart Failure Research
Neprilysin (NEP) is a neutral endopeptidase. Neprilysin inhibitors increase the levels of atrial natriuretic peptides, therefore have beneficial effects for the cardiovascular diseases, including hypertension and heart failure. In addition,…